Risk of death, thrombotic and hemorrhagic events in patients with atrial fibrillation and systemic autoimmune diseases

Back

EHRA Premium Access

Risk of death, thrombotic and hemorrhagic events in patients with atrial fibrillation and systemic autoimmune diseases

Session: Atrial fibrillation: diagnostic - clinical

Topic: Clinical

Speaker: Doctor T. Bucci (Liverpool, GB)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tommaso Bucci

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Associations of fat and muscle mass indices with incident atrial fibrillation: data of PREVEND

Speaker: Doctor N. Suthahar (Rotterdam, NL)

Atrial high-rate episodes detected by cardiac implantable electronic devices: arrhythmic burden and progression towards de-novo clinical atrial fibrillation

Speaker: Doctor J. Imberti (Modena, IT)

In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project

Speaker: Doctor J. Vogler (Luebeck, DE)

The influence of subclavian ansae stimulation on cardiac hemodynamics and electrophysiology in atrial fibrillation- exploring a novel target for neuromodulation in atrial fibrillation (SAS-AF study)

Speaker: Doctor V. Kanthasamy (London, GB)

Access the full session

Atrial fibrillation: diagnostic - clinical

Speakers: Doctor T. Bucci, Doctor N. Suthahar, Doctor J. Imberti, Doctor J. Vogler, Doctor V. Kanthasamy

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources